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Abstract
Background: Plasmodium falciparum erythrocyte membrane protein-1, a variant antigen of the
malaria parasite, is potentially a target for the immune response. It would be important to
determine whether there are CD4 T cells that recognise conserved regions. However, within the
relatively conserved region, there is variation. It is not possible to test T cell responses from small
field samples with all possible peptides.
Methods: We have aligned sequences that are relatively conserved between several PfEMP1
molecules, and chosen a representative sequence similar to most of the PfEMP1 variants. Using
these peptides as pools representing CIDRα , CIDRβ  and DBLβ -δ  domains, DBLα  domain, and
EXON 2 domain of PfEMP1, we measured the CD4 T cell responses of malaria-exposed donors
from Benin, West Africa by a FACS based assay.
Results: All the three peptide pools elicited a CD4 T cell response in a proportion of malaria-
exposed and non-exposed donors. CD4 T cell proliferation occurs at a relatively higher magnitude
to peptide pools from the DBLα  and EXON 2 in the malaria-exposed donors living in Benin than
in the UK malaria-unexposed donors.
Conclusions: These findings suggest that an immunological recall response to conserved peptides
of a variant antigen can be measured. Further testing of individual peptides in a positive pool will
allow us to determine those conserved sequences recognised by many individuals. These types of
assays may provide information on conserved peptides of PfEMP1 which could be useful for
stimulating T cells to provide help to P. falciparum specific B cells.
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Background
Plasmodium falciparum infection is a major source of mor-
bidity and mortality in malaria-endemic areas [1]. The
manifestation of severe malaria is more common in non-
immune children living in, and non-immune visitors to,
endemic regions, suggesting that the acquisition of specif-
ic immunity is an important factor in preventing morbid-
ity and mortality from malaria infection [1]. However, the
immunity to malaria infection is partial, as adults living in
malaria hyper-endemic zone can be parasitaemic or in-
deed develop malarial disease. The immunological mech-
anisms and the antigens to which acquired immunity is
directed, are not fully known, although the erythrocytic
stage of the parasite has been reported to be the primary
target [2]. The variant antigens, expressed on the surface of
P. falciparum infected red blood cells and believed to be a
mechanism of immune evasion by the malaria parasite,
are important antigens worthy of consideration as targets
for malaria immunity. One such antigen used in this study
is  P. falciparum erythrocyte membrane protein-1
(PfEMP1).
PfEMP1 is a highly variant antigen, with the variable do-
mains within the extra-cellular region coded for by EXON
1 and a relatively conserved intracellular region coded for
by EXON 2 (Figure 1). PfEMP1 has been identified as the
molecule responsible for intra-vascular sequestration of P.
falciparum-infected red blood cells [3,4], a factor which
has been associated with the pathogenesis of a severe ma-
laria syndrome (cerebral malaria) [5]. The role of PfEMP1
in cytoadherence, when considered together with the fact,
that antibodies to variants of PfEMP1 have been reported
to occur in people living in malaria-endemic regions, but-
tresses the notion that PfEMP1 is indeed an important tar-
get for malaria immunity. Furthermore, the number of
parasite variants recognised by the sera of these people in-
creases with age and hence, exposure to many parasite var-
iants [2,6]. This indicates that sequential accumulation of
antibodies to the different variant molecules present in
the local malaria parasite population contributes to the
partial immunity that develops to malaria infection. Vari-
ant specific antibody responses are likely to require CD4 T
cell help. CD4 T cells recognising conserved peptides of a
malarial antigen would be potentially more beneficial in
malaria immunity, as a memory response from such T
cells could provide a rapid help for the variant specific an-
tibody responses. However, it is impractical to determine
if a recall response occurs to the conserved portions of a
variant antigen by producing recombinant proteins or
synthetic peptides of the conserved regions of all known
or published sequence of the molecule.
Hence, we have aligned the sequences of published
PfEMP-1 molecules, synthesised a peptide similar to most
peptides in a relatively conserved block and pooled the
peptides into three groups which correspond to regions of
the whole PfEMP1 molecule (Figure 1). The CD4 T cell re-
sponses of malaria-exposed donors (from Benin, West Af-
rica) was determined by a flow cytometry method, and
compared to the CD4 T cell responses of malaria-unex-
posed UK donors. Using this method, we have been able
to show that CD4 T cells responses to conserved regions
of a variant antigen can measured. As the T cell responses
to malarial antigens are often low [7] and it has been sug-
gested that cytokines such as IL-10 may inhibit T cell pro-
liferation [8], we have also measured IL-10 production
after stimulation with the different peptide pools.
Materials and methods
PfEMP1 sequences, alignment and synthesis
Fifteen PfEMP1 sequences were downloaded from the se-
quence database maintained at the National Center for Bi-
otechnology Information via PubMed Medline. Gene
identification number and names of the sequences are as
follows: g1297091, 3D7var1; g6601436, A4 tres var par-
tial; g886375, var-1 Dd2; 1809295, FCR3varT11.1;
g914919, MCvar1; g4760402, varCS2 (CSAP) Like;
g3845343, PFB 1055c; g3540145, Var IT 4/25/5;
g1517814, var ITG 2F6-P21; g914921, var-2 MC132;
g886378, var PF 23AFCR3; g2944095, var prot PNG;
g5163174, var C2 itG Exon 2; VAR7-like molecule of
DD2, (accession number Y11909); and Var MC, (acces-
sion number U27338).
The sequences were then aligned using the Megalign pro-
gram of DNA star computer software. A peptide similar to
most peptides in a relatively conserved block was chosen
and synthesised by 9-Fluorenylmethoxycarbonyl (Fmoc)
chemistry using the multiple peptide synthesiser (Biotech
Instrument Limited) as described [9]. The degree of se-
quence homology of the chosen peptide to the others in a
conserved block is shown in Table 1. Three pools of rela-
tively conserved peptides were prepared as shown in Fig.
1 and Table 1. Since previous studies [10–12] show that
the peptides recovered from purified MHC class II mole-
cules range from 9 to 30 amino acids or more, we have
only chosen peptides from conserved blocks where the
amino acid length is not less than 9. Longer peptides were
included as they would be processed before presentation
by the antigen-presenting cell. Although there are no algo-
rithms or programmes available that can predict MHC
class II-binding peptides with probabilities of greater than
50%, screening of the selected peptides using SYFPEITHI
database epitope prediction programme [13] predicted
that at least 13 out of the peptides used contain one or
more epitopes theoretically able to bind one or more
HLA-DR molecules.Malaria Journal 2002, 1 http://www.malariajournal.com/content/1/1/7
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Donors
The ages of the Benin malaria exposed donors ranged
from 4–45 years (male to female ratio was 4:6). The ages
of the UK unexposed control volunteers ranged from 20–
45 years (male to female ratio was 3:7). Blood (5 mL from
children to 20 mL from adults) was taken from donors liv-
ing in and around Cotonou, Benin during the dry season
of 1992. In this region, malaria is holoendemic with max-
imal transmission during the rainy season [14]. 28% of
the donors were parasitaemic at the time of blood collec-
tion, and parasitaemia ranged from 0.0004% to 0.1%.
None of the UK volunteers had travelled to a malaria en-
demic area at any time. Peripheral blood mononuclear
cells (PBMC) were separated over Ficoll/paque (Pharma-
cia Biotech.) using standard procedures. The cells were re-
suspended in foetal calf serum (FCS) containing 10%
DMSO and frozen by controlled-gradient freezing at -
70°C for 48h and finally in liquid Nitrogen until use. The
Benin samples were transported from Benin to the UK to
be analysed simultaneously with the UK samples that
were frozen using a similar method. We have shown pre-
viously that the CD4 T cell response of PBMC frozen in
this manner is as good as that of freshly isolated cells to
antigens such as tetanus toxoid [15]. Viability of recovered
cells from the Benin samples ranged from 70 to 90% and
above 95% for the UK sample. Ethical approval was given
by the Vice Dean of Medical School of the University of
Benin in accordance with the Helsinki declaration and by
the Barnet Health Authority Ethics Committee, UK.
In vitro assay for cell division
PBMC were thawed rapidly at 37°C, washed twice in
RPMI 1640, centrifuged at 415 g for 5 min at room tem-
perature and counted. The cells were resuspended at 5 ×
106 cells in 250 µL diluent for PKH26 (Sigma) labelling,
and stained for 1 min by incubation with PKH26 dye at
room temperature as described previously [15,16].
PKH26 dye incorporation into cell membrane was
stopped by adding two times the volume of 100% human
AB serum. Cells were then washed three times, and stain-
ing was assessed by flow cytometry. After labelling and
washing the viabililty as assessed by Trypan Blue was
greater than 75%. The labelled cells were re-suspended in
fresh RPMI 1640 medium supplemented with 2 mM
glutamine, 100 U/mL penicillin, 100 µg/mL streptomy-
cin, 10 mM HEPES and 10% heat-inactivated AB serum
medium. The cultures were set up in triplicates at 2 ×  105
cells/well in a 96 well U-bottomed plate (Nunclon™, Gib-
co) in a final volume of 200 µL with or without antigen.
Test antigens were used at a final concentration of 5 nM
for each peptide in a pool. Phytohaemagglutinin (PHA)
(Sigma) was used as a control for cell viability at a final
concentration of 2.0 µg/mL. Plates were incubated at
37°C, 5% CO2, in a humidified atmosphere for 7 days, af-
ter which time supernatants were removed for cytokine
measurement and the cells were stained with monoclonal
antibodies directed against CD3 and CD4. The relative
numbers of dividing CD4+ lymphocytes were determined
by flow cytometry.
Figure 1
Three pools of the relatively conserved peptides from PfEMP1. Pool 1 is from the DBLα  domain, pool 2 contains two peptides
from CIDRα  and ten from DBLβ -δ  and CIDRβ  domains and pool 3 contains conserved peptides from the intracellular EXON
2 domain. The peptides were selected as representative of 15 var gene sequences as described in the Materials and Methods
Section. TM stands for transmembrane region.
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Antibodies for flow cytometry
The antibody used to determine the phenotype of the re-
sponding cells was allophycocyanin (APC) conjugated
anti-CD4, 13B8.2 (mouse IgG1) (Pharmingen).
Cultured cells were washed in sterile PBS containing 0.5%
w/v bovine serum albumin, 5.0 mM EDTA pH 8.0 and
0.01% w/v sodium azide (Sigma) and incubated with the
antibody for 30 mins. Excess antibody was washed off in
PBS and the cells fixed in 1% paraformaldehyde in PBS
and transferred into FACS tubes for analysis.
Measurement of cell division by flow cytometry
Flow cytometry was performed on a FACscalibur machine
using Cell Quest software (Becton Dickinson). Viable cell
population was defined by using forward and 90° light
scatter. A reduction in the fluorescence intensity of PKH26
labelling was used as an index of cell division [15,16]. The
use of APC conjugated antibody allowed the measure-
ment of dividing CD4+ T cells. The flow cytometer was set
to acquire events for 2 min. This allows the relative num-
bers of recovered viable cells within each well (a measure
of the magnitude of the response) to be determined. Any
cell exhibiting a reduction in PKH26 fluorescence intensi-
Table 1: The degree of sequence homology between chosen peptide and variants within relatively conserved blocks of PfEMP1.








Pool 1 Peptides from  11 10 1 1aa:11], 2aa:2, 5aa:4, 7aa:1, 8aa:1
DBLα  regionDBLα GQCTFNRIKDS 12 10 7 1aa:3
12 11 0 2aa:4, 3aa:2, 4aa:4, 1aa:1
GACAPYRRLHLC 19 11 1 1aa:3, 2aa:7
HNLLADVCEAAK 17 11 1 1aa:2, 3aa:3, 1aa:2, 6 aa:2, 10aa:1
ARSFADIGDIVRGKDLYLG 19 11 4 1aa:2, 2aa:4, 3aa:1
LREDWWTANRETVWKAI 12 11 1 2aa:3, 3aa:1, 4aa:1, 6aa:2, 7aa:3
VPTYFDYVPQYLRWFEEWA 16 11 0 2aa:4, 3aa:3, 4aa:2, 5aa:1, 6aa:1
SRNGYDCTKTIR 15 11 0 2aa:2, 3aa:2, 4aa:1, 5aa:3, 6aa:1, 7aa:2
WIDNQKKEFLKQKKKY
TFSHTEYREPCPWCG
Pool 2 peptides from KDSIEWRSKLSNCLK 15 11 1 5aa:2, 6aa:3, 7aa:1, 8aa:3, 9aa:1
CIDRα  and β  and  CRAMKYSFADLGDII 15 6 1 1aa:1, 2aa:3, 4aa:1
DBLβ -δ  regions ICIPPRRRRLYVGKL 15 10 0 1aa:1, 2aa:4, 3aa:1, 4aa:2, 6aa:1, 8aa:1
11 10 2 1aa:3, 2aa:3, 4aa:1, 8aa:1
SAAIETFFLWD 14 9 0 1aa:1, 2aa:1, 3aa:4, 4aa:2, 5aa:1
GVIPPDFLRQMFYT 15 10 1 3aa:5, 4aa:1, 5aa:1, 7aa:1, 10aa:1
IWNGMICALTYKEKD 12 10 4 1aa:2, 2aa:1, 3aa:1, 5aa:1, 7aa:1
RPPYFRYLEEWG 13 6 2 1aa:2, 2aa:2
WMTEWAEWFCKEQ 13 10 1 1aa:2, 5aa:1, 6aa:1 8aa:2, 9aa:1, 10aa:1,
FTYFYLKKKTKSS 11aa:1
IPTKLSPNRYIPYTSGKYRG- 27 10 4 1aa:1, 9aa:2, 22aa:1, 23aa:2
KRYIYLE 10 10 4 1aa:3, 6aa:2, 9aa:1
ESEYEEMDIN 9 7 5 4aa:2
DHYSDITSS
Pool 3 peptides from  DIYVPGSPKYKTLIEVVLEPS 21 8 5 1aa:2, 4aa:1
Exon 2 region 15 10 1 2aa:4, 3aa:2, 4aa:1, 12 aa:2
ITDDEWNQLKKDFIS 11 8 2 1aa:2, 2aa:1, 6aa:1, 7aa:2
VDNNTHPTMSR 10 8 5 1aa:3
KPFIMSIHDR 14 9 3 1aa:3, 3aa:1, 7aa:1, 10aa:1
YSGIDLINDALSGN 19 9 0 1aa:6, 2aa:2, 14aa:1
HIDIYDELLKRKENELFGT 13 8 3 1aa:3, 2aa:2
NLFHKWLDRHRDM 11 8 2 1aa:2, 3aa:2, 5aa:1, 6aa:1
KLKELWENETH 10 7 2 1aa:2, 2aa:1, 4aa:1, 5aa:1
MDTILDDLEK
1] Indicates the number of variant peptides in a conserved block that differs from the peptide used for the T cell assays by the number of amino acids 
shown as "aa" (for example, 5aa:4 means that 4 variant peptides in a conserved block differ from the peptide used for the T cell assay by 5 amino 
acids.Malaria Journal 2002, 1 http://www.malariajournal.com/content/1/1/7
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ty was classified as having divided in response to the anti-
gen. The background number of divided CD4 T cells in
the absence of antigen varied widely between donors (30–
8152), therefore, a donor was considered to have re-
sponded by CD4 T cell division if the mean number of di-
viding cells in triplicate wells containing an antigen was
equal to or above 2 times the mean value of triplicate
wells without antigen. The percentage of dividing CD4
population relative to the total population of CD4 posi-
tive cells ranged from 1.2% – 10%
Detection of cytokines by ELISA
The amount of IL-10 in the supernatants after 7 days of
cultures was measured by ELISA using paired antibody
kits (Pharmingen/ Beckton Dickinson, Oxford, UK) and
following the manufacturers instructions. The response of
a donor was defined as positive when the mean concen-
tration of IL-10 produced in triplicate wells containing an-
tigen was significantly greater (i.e. p < 0.05, Student T test)
than the mean concentration of IL-10 production in trip-
licate wells without antigen of that donor.
The limit of detection for the ELISA assay for IL-10 was 4
pg/mL. The background level of IL-10 production differed
widely between individual donors (range: 0 to 149 pg/
mL). For this reason, the concentration of IL-10 produced
by each donor in response to the peptide antigens was tak-
en as the net concentration after subtraction of the back-
ground of that donor without antigen. Standard Errors of
the means were usually in the range of 15–20% (not
shown).
Statistical analyses
The results were analysed by the Two-tailed Student T test
and the Fisher's exact Test.
Results
Prevalence and magnitude of the CD4 T cell proliferation
We have determined the in vitro CD4 T cell division in re-
sponse to three pools of relatively conserved peptides
from three regions of PfEMP1, namely, DBLα  (pool 1),
CIDRα  and CIDRβ  + DBL β -δ  (pool 2) and EXON 2 (pool
3) (Table 1 and Figure 1). All the three peptide pools elic-
ited a CD4 T cell response in a proportion of malaria-ex-
posed and non-exposed donors (Figure 2). The
magnitude of the CD4 T cell division was significantly
higher in the Benin malaria-exposed donors when com-
pared to the UK malaria-unexposed donors for peptide
pools 1 and 3 (Two tailed Student T test, p = 0.025 and
0.045 for peptide pools 1 and 3, and p = 0.062 for pool 2
peptides) (Table 2). Using a cut off of 2 stimulation indi-
ces to define a positive response, the prevalence of posi-
tive CD4 T cell response among the malaria-exposed
Benin donors to any of the three peptide pools ranged
from 21–37% (Figure 2). However, using the Fisher's Ex-
act test, this was not statistically different from the preva-
lence of the responders among the UK malaria-unexposed
donors (4–20%) (Figure 2). The absence of CD4 T cell di-
vision in response to the antigens by some donors was not
due to loss of cellular viability, as cells from all donors di-
vided in response to PHA, (data not shown).
Prevalence and magnitude of cytokine production
IL-10 was measured in the supernatants after 7 days of cul-
ture in the presence of the three PfEMP-1 peptide pools.
The prevalence of positive IL-10 responses to any of the
peptide pools ranged from 16–21% among the malaria-
exposed donors living in Benin and ranged from 0–7%
among the malaria-unexposed UK. Because of the small
sample size, the differences observed in the prevalence of
positive IL-10 responders between the Benin malaria-ex-
posed donors and the UK malaria-unexposed donors was
not statistically significant, using the Fisher's Exact test
(data not shown). The magnitude of IL-10 production was
significantly higher only in the culture supernatants of the
Benin malaria-exposed donors stimulated with pool 3
(EXON 2) peptides when compared with the magnitude
of IL-10 production in the culture supernatants of the UK
non-exposed donors (31.1 ± 10.4 pg/mL and 3.4 ± 1.2 pg/
mL respectively; p = 0.03).
Comparison of IL-10 production and CD4 T cell division
for each donor indicated an inverse correlation between
the 2 responses (Figure 3). UK donors with positive IL-10
production to peptides pools 2 and 3 had no positive CD4
T cell response. Conversely, those UK donors whose CD4
T cells divided in response to the peptide pools did not
produce IL-10 (Figure 3). Amongst the Benin donors, only
those with the lowest CD4 T cell division produced IL-10
(27% of donors).
Discussion
In this study we have shown that the magnitude of the
CD4 T cell response to peptide pools representing parts of
DBLα  and Exon 2 domains of PfEMP1 (Table 2) was sig-
nificantly higher in the Benin malaria-exposed donors
when compared to the UK malaria-unexposed donors.
These results suggest that, despite the extensive variation
of PfEMP1, exposure to P. falciparum may induce a CD4 T
cell response to conserved or shared regions of DBLα  and
EXON 2 of this molecule. A more detailed study with a
larger number of PBMC from immune adults would allow
us to determine whether individual peptides within these
pools were responsible for the enhanced responses, and
thus whether conserved peptides might be useful for elic-
iting CD4 T cells that are able to help variant specific B cell
responses.
All CD4 T cell divisions to the peptides were relatively
small; only rarely were divisions of greater than 5 stimula-Malaria Journal 2002, 1 http://www.malariajournal.com/content/1/1/7
Page 6 of 8
(page number not for citation purposes)
tion indices observed (Figure 2). These results agree with
several earlier studies showing low T cell responses to a va-
riety of malaria antigens [7,16–18] which may in part be
caused by selective sequestration of specific cells in lym-
phoid organs [19,20]. It is also possible in our case that ei-
ther the peptides selected did not bind the different MHC
Class II molecules, or they were not representative of the
repertoire of PfEMP1 molecules in the parasite population
of this endemic area.
The repertoire of PfEMP1 molecules expressed on para-
sites in this or any area of P. falciparum transmission is not
known. Since the conservation between the fifteen vari-
ants sequenced from a variety of parasites from different
areas was high, we would expect some of these peptides to
be representative of those in the sample population. As
tools become available that enable characterisation of the
PfEMP1 molecules in different parasites, it will become
possible to test T cell responses against peptides from
PfEMP1 that are known to be expressed in the parasites in-
fecting the individuals under study.
CD4 T cell responses can be inhibited in vitro and in vivo
by cytokines such as TGFβ  and IL-10 [21,22]. Therefore we
determined whether IL-10 was produced in the culture su-
pernatants of PBMC from Benin and UK donors in re-
sponse to the three peptide pools. Here we show that
greater amounts of IL-10 were produced in the cultures of
the Benin malaria-exposed donors stimulated with pool 3
(EXON 2) peptides. Exposed or non-exposed donors,
whose cultures produced high levels of IL-10 in response
to any of the peptide pools generally had no or low CD4
T cell responses and vice versa. These data, although from
a small sample, suggest that strong IL-10 responses are not
Figure 2
CD4 T cell division in response to the three pools of the relatively conserved peptides determined by flow cytometry using
PKH26 dye. The results are expressed as stimulation indices; i.e. the mean number of dividing cells in triplicate wells containing
an antigen divided by the mean number of dividing cells in triplicate wells without antigen. All responses with stimulation indi-
ces greater than or equal to 2 were considered as positive (i.e. those with values above the horizontal line shown on each of

























































DBLα  (pool 1) CIDRα  + DBLβ -δ (pool 2) Exon 2 (pool 3)
Fisher's 
Exact test p = 0.22 p = 0.18 p = 0.10
Table 2: CD4 T cell proliferation to three pools of relatively con-
served peptides of PfEMP-1
Pools of peptides Mean CD4 T cell proliferation (Log10)
Benin donors UK controls P value
DBLα  
(pool 1)
2.47 ± 0.15 1] (24)2] 1.94 ± 0.18 (24) P = 0.025
CIDRα  + DBLβ -δ  
(pool 2)
2.47 ± 0.14 (23) 2.02 ± 0.20 (21) P = 0.062
Exon 2 
(pool 3)
2.44 ± 0.15 (24) 1.94 ± 0.20 (22) P = 0.045
1] Standard error of the Log10 mean of dividing CD4 T cells in tripli-
cate wells as determined by a flow cytometric assay described in 
Materials and Methods 2] Total number of donors testedMalaria Journal 2002, 1 http://www.malariajournal.com/content/1/1/7
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compatible with CD4 T cell proliferation in vitro. Prolifer-
ation assays carried out in the presence of anti-IL-10 anti-
bodies or anti-IL-10 receptor antibodies would clarify the
anti-proliferative role of IL-10 in these responses; such
studies are underway. The fact that a small fraction of ma-
laria-unexposed UK donors also respond to these peptide
pools could indicate that there are cross-reactive or shared
T cell epitopes with other antigens among the three pep-
tides pools used in the in vitro stimulation as has been de-
scribed earlier for some malaria antigen specific T cell
clones [23].
Our data suggest that the use of synthetic peptides repre-
senting conserved sequences of PfEMP1 might be of value
in determining regions of the molecule recognised by T
cells of a wide variety of donors exposed to different vari-
ants of PfEMP1. Further dissection of the responses to in-
dividual peptides may allow us to select regions of
PfEMP1 that could be useful for a peptide-based vaccine.
It would be very encouraging for vaccine design if CD4 T
cell helper responses for variant specific B cells could be
directed to common or conserved regions of PfEMP1.
Conclusion
In summary, we have shown that CD4 T cell division to
conserved peptides of some regions of PfEMP1 occurs at a
relatively higher magnitude in donors living in a malaria
endemic zone when compared with malaria-unexposed
donors. These findings indicate a secondary response to
these peptides and, hence, have important implications in
malaria vaccine development, as the relatively conserved
peptides inducing the T cell division might be useful for
stimulating variant specific B cell help in a multi-compo-
nent vaccine. At present, we have used peptide mixtures
from different regions of PfEMP1 because of limitations
in the number of PBMC available from each donor. An
important extension of this work is to map out the specific
peptides responsible for the induction of the observed
CD4 T cell division in the responders and determine
whether other variants of the peptides produce a similar
response or act as altered peptide ligands. The response of
individuals with different HLA class II haplotype to these
peptides would also determine their usefulness in vacci-
nation.
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